Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Chemotherapy/Chemoradiotherapy in Esophageal Carcinoma
NCT00733889Phase 2Completed
- Sponsor
- Spanish Cooperative Group for Digestive Tumour Therapy
- Start
- Dec 2006
- Primary completion
- Nov 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in esophageal carcinoma, sponsored by Spanish Cooperative Group for Digestive Tumour Therapy. Started Dec 2006; status: completed.
02
Drugs
KL-140
03
Conditions
esophageal carcinoma
Beyond the preview
Go deeper on NCT00733889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00733889.